FDA Yanks Ozone-Depleting Inhaler From Market
The U.S. Food and Drug Administration announced Thursday it was taking the only agency-approved over-the-counter asthma inhaler off the market at the end of the year because it uses a compound...To view the full article, register now.
Already a subscriber? Click here to view full article